Opthea (OPT) News Today → Central Banks Preparing for US Dollar Collapse? (From Behind the Markets) (Ad) Free OPT Stock Alerts Add Compare Share Share HeadlinesStock Analysis All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineOpthea Ltd ADR OPTmorningstar.com - March 19 at 2:28 PMOpthea Limited: Opthea Reports Half-Year Financial Results and Business Updatesfinanznachrichten.de - February 29 at 2:16 PMBuy Rating for Opthea Limited on Promising Phase 2b Results of Sozinibercept for Wet AMDmarkets.businessinsider.com - February 29 at 2:16 PMOpthea Appoints Arshad M. Khanani, MD, MA, FASRS, as Chief Medical Advisorfinance.yahoo.com - February 19 at 9:04 PMOpthea Limited (CKDXF) stock price, news, quote & history – Yahoo Financenz.finance.yahoo.com - February 18 at 6:35 PMASX Health Stocks: Clarity’s imaging agent can identify prostate cancer lesions at double the ratemsn.com - February 14 at 8:47 PMOpthea Limited: Opthea Strengthens Team with Key Clinical and Regulatory Hiresfinanznachrichten.de - February 2 at 10:48 AMMarket Highlights: Meta surges 14pc, uranium stocks most traded by Aussies, and 5 small caps to watch todaymsn.com - February 2 at 10:48 AMOpthea Strengthens Team with Key Clinical and Regulatory Hiresfinance.yahoo.com - February 1 at 8:23 AMWhy Opthea, Pantoro, Premier Investments, and Wildcat shares are fallingfool.com.au - January 8 at 9:03 PMOpthea Receives A$8.8 million R&D Tax Incentivefinance.yahoo.com - December 19 at 8:24 AMOpthea Limited’s Strong Financial Standing and Promising Drug Candidate Secure a Buy Rating: An Analysis by Chris Coopermarkets.businessinsider.com - October 17 at 7:26 AMOpthea to Participate at the 2023 Euretina Congressfinance.yahoo.com - October 2 at 9:49 AMJonesTrading Sticks to Its Buy Rating for Opthea Limited Sponsored ADR (OPT)markets.businessinsider.com - September 14 at 5:33 PMCheck Up: Australian biotech sector continues to be a magnet for US investorsmsn.com - August 30 at 10:21 PMOpthea Shares Dropped 12% After A$90M Raised in Placementmarketwatch.com - August 28 at 12:44 PMOpthea raises additional capital, up to $57.6Mmsn.com - August 28 at 7:44 AMOpthea Successfully Completes Institutional Offer and Increases Capital Raising to A$90.0m (US$57.6 million¹)finance.yahoo.com - August 28 at 7:44 AMAnalysts Offer Insights on Healthcare Companies: Opthea Limited (OtherCKDXF) and Glaukos (GKOS)markets.businessinsider.com - July 27 at 12:09 AMOpthea Announces “Sozinibercept” as the Nonproprietary Drug Name for OPT-302finance.yahoo.com - July 27 at 12:09 AMOPT - Opthea Limitedau.finance.yahoo.com - July 19 at 8:04 PMOpthea to Feature at the American Society of Retina Specialists 2023 Annual Meetingfinance.yahoo.com - July 13 at 8:49 AMOpthea Appoints Anshul Thakral as Non-Executive Director of the Boardfinance.yahoo.com - June 8 at 7:12 AMOpthea To Present at the JMP Securities Life Sciences Conferencefinance.yahoo.com - May 8 at 7:43 AMOpthea To Participate at the H.C. Wainwright BioConnect Conference at NASDAQfinance.yahoo.com - April 28 at 8:59 AMAnalysts Offer Insights on Healthcare Companies: Opthea Limited Sponsored ADR (OPT) and Humacyte (HUMA)markets.businessinsider.com - April 27 at 5:57 PMWILSONS Maintains OPTHEA (ASX:OPT) Overweight Recommendationmsn.com - April 22 at 12:27 AMEF Hutton Initiates Coverage On Opthea with Buy Rating, Announces Price Target of $23benzinga.com - April 19 at 10:52 PMOpthea shares are trading higher after EF Hutton initiated coverage on the stock with a Buy rating and a $23 price target.benzinga.com - April 17 at 2:10 PMOpthea receives $6.3M in R&D Tax Incentivemsn.com - March 7 at 10:13 AMOpthea Receives A$8.7 million R&D Tax Incentivefinance.yahoo.com - March 7 at 10:13 AMOpthea First Half 2023 Earnings: US$0.17 loss per share (vs US$0.11 loss in 1H 2022)finance.yahoo.com - February 24 at 5:14 PMOpthea Phase 2b Trial Results of OPT-302 in Combination with Lucentis® for wet AMD Published in the Journal Ophthalmologyfinance.yahoo.com - February 13 at 7:05 AMThe chances of Phase 3 success, and the ASX health stocks that are close a home runmsn.com - February 8 at 2:18 PMOpthea To Present at SVB Leerink Global Biopharma Conferencefinance.yahoo.com - February 6 at 9:14 AMOpthea To Present at Sequire Biotechnology Conferencefinance.yahoo.com - January 30 at 10:40 AMOpthea Limited (OPT) Stock Historical Prices & Data - Yahoo Financefinance.yahoo.com - January 20 at 11:10 PMOpthea Limited (OPT.AX)finance.yahoo.com - January 12 at 1:23 PMOpthea Announce MST Access Hosted Conference Call with Professor Jason S. Slakter, MDfinance.yahoo.com - December 12 at 10:39 AMOpthea Limited's (ASX:OPT) top owners are individual investors with 44% stake, while 26% is held by hedge fundsfinance.yahoo.com - December 9 at 5:53 PMOpthea to Present at Jefferies London Healthcare Conferencefinance.yahoo.com - November 10 at 5:45 PMHere's Why Opthea (ASX:OPT) Must Use Its Cash Wiselyfinance.yahoo.com - September 18 at 7:56 PMOpthea Announces Presentation at H.C. Wainwright 2nd Annual Ophthalmology Virtual Conferencefinance.yahoo.com - August 16 at 9:22 AMWhy did the Opthea share price dive 9% on Monday?fool.com.au - August 15 at 4:29 AMOpthea Successfully Closes Well Supported US$90...benzinga.com - August 14 at 10:20 PMOpthea Secures up to US$170 Million in Non-Dilutive Financing for OPT-302 in wet AMDapnews.com - August 14 at 10:20 PMCarlyle chases potential four-bagger at biotech Optheaafr.com - August 11 at 12:52 PMEye therapies group Opthea in $US240m funding deal, chases equity legafr.com - August 10 at 9:39 PMOpthea Presentation at The Retina World Congress 2022finance.yahoo.com - May 10 at 1:09 PMOpthea Presenting Clinical Data at ARVO 2022 Annual Meetingfinance.yahoo.com - April 29 at 9:13 AM Get Opthea News Delivered to You Automatically Sign up to receive the latest news and ratings for OPT and its competitors with MarketBeat's FREE daily newsletter. Email Address Central Banks Preparing for US Dollar Collapse? (Ad)China is spearheading this blatant de-dollarization push, dominating the physical gold market through massive central bank buying. Their ultimate goal? Ditching the greenback in favor of local BRICS currencies. Find out how you can protect yourself now >>> OPT Media Mentions By Week OPT Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. OPT News Sentiment▼0.000.61▲Average Medical News Sentiment OPT News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. OPT Articles This Week▼00▲OPT Articles Average Week Get Opthea News Delivered to You Automatically Sign up to receive the latest news and ratings for OPT and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: AGNPF News AKBLF News DRTSW News ARNI News ARTLW News ASCLF News AVCTF News AWKNF News AXIM News BRRGF News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (ASX:OPT) was last updated on 3/29/2024 by MarketBeat.com Staff From Our PartnersDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsTop Project Outperforms BTC in 2023…Crypto 101 MediaMake This $3 Trade the Instant the Opening Bell RingsMonument Traders Alliance“The Stock Market’s Bull Run is Far from Over” -BarronsVertical Research AdvisoryAI Cracks Open Largest Untapped Energy Reserve on EarthBanyan Hill PublishingThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyMost important medical advance in 100 yearsThe Oxford ClubBuy this small stock before coming AI Tidal WaveChaikin Analytics Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Opthea Limited Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.